Ultrasound assessment of enthesitis can effectively distinguish patients with vs without SpA, with inflammatory B-mode lesions serving as the strongest independent marker.

Patients with hidradenitis suppurativa (HS) may have subclinical spondyloarthritis (SpA) features, e.g., sacroiliitis and ...

Sustained long-term safety data for tildrakizumab strengthens the positioning of IL-23 inhibitors as a preferred choice, ...

Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

Influenza vaccine uptake among children with JIA in Central and Eastern Europe increased from 18.6% before the COVID-19 pandemic to 24.1% in 2021.

Background A 14-year-old boy with a 6-year history of recurrent arthritis and enthesitis, which had not responded to previous treatment with NSAIDs, sulfasalazine and methotrexate, presented with a ...

Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092] Technology appraisal guidance TBC Ruxolitinib for treating moderate to severe chronic graft-versus-host disease ...

Elamipretide for treating Barth syndrome in people of any age [ID6545] Technology appraisal guidance Elinzanetant for treating vasomotor symptoms associated with menopause [ID6359] Technology ...

Novartis' phase III PREVENT trial of Cosentyx in patients with nr-axSpA meets primary endpoint: Basel Wednesday, November 13, 2019, 09:00 Hrs [IST] Novartis, a leader in rheumatol ...

Long-term treatment with risankizumab led to sustained improvements across all GRAPPA-recognized domains of psoriatic arthritis over 100 weeks. Treatment with risankizumab leads to durable ...

Centre for Rheumatic Diseases, University Department of Medicine, Glasgow Royal Infirmary, Scotland, UK Correspondence to: Dr P V Balint, Centre for Rheumatic Diseases, University Department of ...